Scarica l'app Stockscreener
1.16
4.92%
-0.06
Dopo l'orario di chiusura:
1.15
-0.01
-0.86%
Precedente Chiudi:
$1.22
Aprire:
$1.22
Volume 24 ore:
193.29K
Relative Volume:
1.12
Capitalizzazione di mercato:
$27.62M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-0.7401
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
-30.95%
1M Prestazione:
-53.04%
6M Prestazione:
-59.72%
1 anno Prestazione:
-70.36%
Intervallo 1D:
$1.15
$1.245
Intervallo di 1 settimana:
$1.15
$1.72
Portata 52W:
$1.15
$7.97
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.16 | 27.62M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
CELU Stock Touches 52-Week Low at $1.29 Amid Market Challenges By Investing.com - Investing.com South Africa
Celularity receives FDA TRG recommendation letters for Natalin, Acelagraft - MSN
Celularity Enters Strategic Collaboration Agreement with BlueSphere Bio to Support Cell Therapy Manufacturing - Defense World
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products - The Manila Times
Celularity Secures Crucial FDA Pathway for Wound Care ProductsCan They Capture Share of $810M Market? - StockTitan
Celularity inks manufacturing deal with BlueSphere Bio By Investing.com - Investing.com Australia
Celularity inks manufacturing deal with BlueSphere Bio - Investing.com
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company - The Manila Times
Can This New Cell Therapy Manufacturing Deal Transform Celularity's Revenue Potential? - StockTitan
Celularity Inc.'s (NASDAQ:CELU) Business And Shares Still Trailing The Industry - Simply Wall St
Celularity Inc. Extends Loan Agreements with Resorts World Inc and C.V. Starr & Co. - Defense World
SEC Form FWP filed by Celularity Inc. - Quantisnow
Celularity Inc (CELU) Stock: Analyzing the Market Value - The News Heater
Celularity Inc (CELU) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Placental Stem Cell Therapy Solution Market Size And Booming - openPR
Celularity files to sell 6.52M shares of Class A common stock, warrants - MSN
Celularity cancels material agreement with investor - MSN
Celularity amends warrant terms, secures $2.46 million funding By Investing.com - Investing.com Canada
Celularity amends warrant terms, secures $2.46 million funding - Investing.com India
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs - The Manila Times
Celularity cancels material agreement with investor By Investing.com - Investing.com
Celularity Faces Challenges as Agreement Expires - TipRanks
Celularity Inc. (NASDAQ:CELU) Short Interest Up 7.1% in December - Defense World
Celularity (NASDAQ:CELU) Shares Down 0.5% – Here’s What Happened - Defense World
Amniotic Products Global Industry Report 2025: Growth in Regenerative Medicine Propels the Use of Amniotic Products in Tissue Repair and Healing - GlobeNewswire Inc.
**Celularity Inc. Holds Annual Meeting and Reports Voting Results** - Defense World
CELUCelularity Inc. Latest Stock News & Market Updates - StockTitan
Celularity announces resolution of Nasdaq listing compliance matter - Nasdaq
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times
Celularity Restores Nasdaq Compliance After Major Financial Reporting Overhaul - StockTitan
Celularity reports Q3 EPS (73c) vs. ($4.98) last year - MSN
Celularity Gets Back On Track With Quarterly Submissions; Q3 Revenue Jump 145% - Nasdaq
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - The Manila Times
Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third - EIN News
Celularity Inc. (CELU) reports earnings - Quartzy
Celularity Reports Explosive 621% Product Sales Growth, Returns to Nasdaq Compliance - StockTitan
Celularity Inc. announced that it expects to receive $1 million in funding - Marketscreener.com
Celularity Inc faces Nasdaq delisting over late filing By Investing.com - Investing.com South Africa
Celularity Inc faces Nasdaq delisting over late filing - Investing.com
Celularity Inc. Announces Receipt of Nasdaq Notification - The Manila Times
Celularity announces receipt of Nasdaq notification - MSN
Celularity faces Nasdaq delisting over filing delay - Investing.com India
Celularity Faces Nasdaq Non-Compliance Notice Over Delayed Q3 Filing | CELU Stock News - StockTitan
Genting breaks ground on stem cell facility in Bali, Indonesia - theSun
Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific - The Manila Times
Celularity Partners with Genting to Build $7.2B Market-Targeting Stem Cell Facility in Bali | CELU Stock News - StockTitan
Celularity Resolves Nasdaq Compliance Issue, Maintains Listing After Filing Reports | CELU Stock News - StockTitan
Celularity Inc. (NASDAQ:CELU) Sees Large Increase in Short Interest - MarketBeat
After-Market Momentum: Celularity (CELU) Shares Climb On Increased Guidance - Stocks Telegraph
Celularity sets annual meeting date, stockholder proposal deadline By Investing.com - Investing.com Canada
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Celularity Inc Azioni (CELU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.22%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):